Latest / Straight From The Cutter's Mouth: A Retina Podcast
Episode 505: SOL-1 Trial Result Discussion with Drs. Jeffrey Heier and Peter Kaiser
Drs. Jeffrey Heier and Peter Kaiser of Ocular Therapeutix join to discuss the SOL-1 trial results investigating a novel tyrosine kinase inhibitor for wet age-related macular degeneration. Conflicts of Interest: Dr. Sridhar has consulted on an advisory board in the past 24 months for Ocular Therapeutix. Dr. Heier and Dr. Kaiser are employed by Ocular Therapeutix.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.